Latest News

BRIAN MEHLING, MD EARNS ANTI-AGING AND REGENERATIVE MEDICINE BOARD CERTIFICATION

Posted by on Jan 5, 2022 in news | 0 comments

BRIAN MEHLING, MD EARNS ANTI-AGING AND REGENERATIVE MEDICINE BOARD CERTIFICATION

Brian Mehling, MD has successfully completed all components of the Board Certification in the field of Anti-Aging and Regenerative Medicine.Dr. Mehling is the founder and chief medical officer of Mehling Orthopedics and BHI Therapeutic Sciences (BHITS). He is a practicing American orthopedic trauma surgeon, researcher, and philanthropist. He spearheads groundbreaking research in stem cell therapy. Notably, BHITS is currently engaged in an FDA Investigational New Drug trial for stroke, using human umbilical cord blood (hUCB) stem...

read more

Brian Mehling, M.D., and team travel to Monaco for potential investors

Posted by on Dec 2, 2021 in news | 0 comments

Brian Mehling, M.D., and team travel to Monaco for potential investors

Brian Mehling, M.D., M.S.founder and chief medical officer of Blue Horizon International (BHI) and his team traveled to Monaco and Paris, France in November 2021, attending a series of meetings with potential investors and partners to expand access to stem cell therapeutics. #BlueHorizonStemCells #StemCellTherapy #Monaco...

read more

Brian Mehling, M.D. and his team attended the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) at the San Diego Convention Center

Posted by on Dec 2, 2021 in news | 0 comments

Brian Mehling, M.D. and his team attended the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) at the San Diego Convention Center

Brian Mehling, M.D. and his team attended the Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) at the San Diego Convention Center, CA from August 31- September 3, 2021.AAOS is the world’s largest meeting of orthopaedic surgeons, researchers, and allied health professionals.Dr. Mehling is the chief medical officer at BHI Therapeutic Sciences, LLC, a company that offers a novel method of arthritis therapy using a patient’s own stromal vascular fraction (SVF) cells including mesenchymal stem cells.BHI Therapeutic...

read more

Chelsea Film Festival

Posted by on Dec 2, 2021 in news | 0 comments

Chelsea Film Festival

Brian Mehling, M.D. hosted a gathering for filmmakers during the Chelsea Film Festival at his home in New York City on Friday October 15, 2021.Dr. Mehling is also a documentary film producer. He is president and CEO of Industrial Motion Pictures (IMP), producer of the film Tiny Tears, which debuted at the prestigious Cannes Film Festival. Their newest film, titled “Stem Cells: The Revolution Is Here” was part of the Chelsea Film Festival this year. DrBrianMehling #BlueHorizonStemCells ChelseaFilmFestival...

read more

Brian Mehling, MD presented at the Annual Congress of Society for Brain Mapping & Therapeutics in Los Angeles

Posted by on Aug 5, 2021 in news | 0 comments

World leading translational neuroscience foundation highlighted the pioneering scientific, technological, advocacy, and policy work at the Ritz Carlton/JW Marriott in Downtown LA on July 10, 2021 The conference was the first in-person major medical conference in California after the state reopened.Dr. Brian Mehling is the founder and chief medical officer of BHI Therapeutic Sciences. He is a practicing American orthopedic trauma surgeon, researcher, and philanthropist. He is spearheading groundbreaking research in stem cell therapy focused...

read more

Sequel to Stem Cells: The Next Frontier (Documentary) coming this summer

Posted by on Mar 11, 2021 in news | 0 comments

Sequel to Stem Cells: The Next Frontier (Documentary) coming this summer

The stem cells documentary Stem Cells: The Next Frontier will be getting a sequel made which is due to come out this summer. The documentary is scheduled to be released just in time for the Cannes Film Festival 2021 which begins on July 6th and ends on July 17th of this year. Stay tuned for more...

read more

Brian Mehling, M.D. presented at the Neuroscience 20 | SBMT virtual summit on November 21, 2020

Posted by on Dec 3, 2020 in news | 0 comments

The title of Dr. Mehling’s presentation is “Umbilical Cord Blood Stem Cell Therapy for Spinal Cord Injury.”Spinal cord injury (SCI) is a common type of severe trauma often resulting in a permanent neurologic deficit. The current retrospective cohort study is aimed to analyze the muscle, nerve, urinary, and gastrointestinal function in SCI subjects treated with either human Umbilical Cord Blood Mononuclear Cells (hUCMNCs) or conventional therapy. Thirty patients with spinal cord injury were randomly selected from seventy...

read more